Digital Therapeutics for Chronic Pain Market
完整報告名稱與涵蓋範圍
Digital Therapeutics for Chronic Pain Market Size, Share & Trends Analysis Report, By Therapeutic Approach (Cognitive Behavioral and Pain Reprocessing Therapy Applications, Virtual Reality Pain Therapeutics, Digitally Delivered Exercise, Physical Therapy and Movement Programs, Biofeedback, Neuromodulation-Linked and Multimodal Programs), By Indication (Chronic Low Back and Musculoskeletal Pain, Fibromyalgia, Neuropathic and Widespread Pain, Migraine and Headache, Post-Surgical and Acute-to-Chronic Pain Transition), By Business Model (Prescription Digital Therapeutics, Employer and Payer-Sponsored Programs, Direct-to-Consumer Subscriptions), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The digital therapeutics for chronic pain market covers software-based interventions that treat chronic pain through cognitive behavioural and pain reprocessing therapy, virtual reality, digitally delivered exercise and physical therapy and biofeedback and multimodal programs, delivered as prescription digital therapeutics, employer and payer-sponsored programs or direct-to-consumer subscriptions across musculoskeletal, neuropathic, migraine and post-surgical pain. Wearable neuromodulation devices and general wellness apps are excluded; the broader digital therapeutics market is addressed in an existing InsightAce study.
Demand is driven by the prevalence of chronic pain, the imperative to reduce opioid reliance, evidence from randomised trials supporting virtual reality and behavioural programs, employer spending on musculoskeletal care and reimbursement developments including new codes for digital mental health and behavioural treatment devices. Employer-sponsored digital musculoskeletal programs have achieved substantial scale by combining sensor-guided exercise with coaching, while prescription virtual reality and behavioural products pursue coverage through regulatory authorisation and payer contracts. Companies compete on outcomes evidence, engagement and retention, integration with clinical care and pricing models tied to results, and consolidation is underway as reimbursement uncertainty pressures smaller developers.
North America leads through employer programs and reimbursement pathways, with Germany's digital health application framework, the United Kingdom and Australia expanding and Asia Pacific in early adoption. Competition involves digital musculoskeletal leaders, virtual reality therapeutics companies, behavioural pain application developers and diversified digital health platforms.
The InsightAce study supplies US$ forecasts for all therapeutic approach, indication, business model and end user and regional segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Digital Therapeutics for Chronic Pain Market Snapshot
Chapter 4. Global Digital Therapeutics for Chronic Pain Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Therapeutic Approach Estimates & Trend Analysis
5.1. Therapeutic Approach & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Therapeutic Approach:
5.2.1. Cognitive Behavioral and Pain Reprocessing Therapy Applications
5.2.2. Virtual Reality Pain Therapeutics
5.2.3. Digitally Delivered Exercise, Physical Therapy and Movement Programs
5.2.4. Biofeedback, Neuromodulation-Linked and Multimodal Programs
Chapter 6. Market Segmentation 2: By Indication Estimates & Trend Analysis
6.1. Indication & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Indication:
6.2.1. Chronic Low Back and Musculoskeletal Pain
6.2.2. Fibromyalgia, Neuropathic and Widespread Pain
6.2.3. Migraine and Headache
6.2.4. Post-Surgical and Acute-to-Chronic Pain Transition
Chapter 7. Market Segmentation 3: By Business Model Estimates & Trend Analysis
7.1. Business Model & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Business Model:
7.2.1. Prescription Digital Therapeutics
7.2.2. Employer and Payer-Sponsored Programs
7.2.3. Direct-to-Consumer Subscriptions
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Patients and Consumers
8.2.2. Employers and Health Plans
8.2.3. Providers and Health Systems
Chapter 9. Digital Therapeutics for Chronic Pain Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. AppliedVR, Inc.
11.2. Hinge Health, Inc.
11.3. Sword Health, Inc.
11.4. Kaia Health GmbH
11.5. Curable Inc.
11.6. Lin Health
11.7. Fern Health
11.8. RelieVRx Programs (AppliedVR)
11.9. Omada Health, Inc.
11.10. Vori Health
11.11. Swing Therapeutics, Inc.
11.12. Orexo AB (Digital Therapeutics)
11.13. Mahana Therapeutics
11.14. Big Health Inc.
11.15. Reliefband Technologies LLC (Adjacent)
圖表清單 List of Tables & Figures
Table 1. Global Digital Therapeutics for Chronic Pain Revenue Forecast by Therapeutic Approach, 2026-2035 (US$ Mn)
Figure 1. Global Digital Therapeutics for Chronic Pain Market Snapshot, 2026 & 2035
Table 2. Global Digital Therapeutics for Chronic Pain Revenue Forecast by Indication, 2026-2035 (US$ Mn)
Figure 2. Global Digital Therapeutics for Chronic Pain Market Share by Indication, 2026 & 2035
Table 3. Global Digital Therapeutics for Chronic Pain Revenue Forecast by Business Model, 2026-2035 (US$ Mn)
Figure 3. Digital Pain Therapeutic Approaches and Their Clinical Evidence Base by Indication
Table 4. Global Digital Therapeutics for Chronic Pain Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Reimbursement Pathways for Prescription and Employer-Sponsored Digital Pain Programs by Region
Table 5. North America Digital Therapeutics for Chronic Pain Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Digital Therapeutics for Chronic Pain Growth Opportunity Analysis
Table 6. Europe Digital Therapeutics for Chronic Pain Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Engagement, Retention and Outcome Metrics Across Digital Pain Platforms
Table 7. Asia Pacific Digital Therapeutics for Chronic Pain Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Competitive Positioning of Key Digital Therapeutics for Chronic Pain Market Participants
Table 8. Latin America and Middle East & Africa Digital Therapeutics for Chronic Pain Revenue Forecast, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們